SPARQ
LIVE

Serial Number

98890822

Owner

Quantabio, LLC

Attorney

Randolph E. Digges, III

Filing Date

Dec 8, 2024

Add to watchlist:

No watchlists yet
View on USPTO

SPARQ Trademark

Serial Number: 98890822 • Registration: 8249240

SPARQ is a trademark filed by Quantabio, LLC on December 8, 2024. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

Quantabio, LLC

100 Cummings Center, Suite 407J
Beverly, MA 01915

Entity Type: 16

Trademark Details

Filing Date

December 8, 2024

Registration Date

May 12, 2026

Published for Opposition

October 7, 2025

Goods & Services

Nonmedical reagents, enzymes and buffer solutions for scientific and/or medical research use, for sample preparation, modification and manipulation of cells and for marking, separating, isolating, purifying, duplicating, sequencing and/or for the analysis of biopolymers, in particular nucleic acids, proteins, macromolecules and biologically active substances, in particular reagents, enzymes and buffer solutions for nucleic acid purification, enrichment, amplification and sequencing; mineral coated particles, artificial and synthetic resins in the form magnetic or superparamagnetic particles, for use in isolating nucleic acids or proteins; kits comprising chemicals for sample preparation, modification and manipulation of cells; kits comprising chemicals for marking, separating, isolating, purifying, duplicating, sequencing and/or for the analysis of biopolymers, in particular nucleic acids, proteins, macromolecules and biologically active substances, in particular nucleic acids of biological or biochemical sample material; kits comprising in particular chemicals for reagents, enzymes and buffer solutions for nucleic acid purification, enrichment, amplification and sequencing

Preparations for medical and veterinary purposes for sample preparation, and for marking, separating, isolating, purifying and/or for the analysis of biopolymers, in particular nucleic acids, proteins, macromolecules and biologically active substances, in particular reagents, enzymes and buffer solutions for nucleic acid purification and enrichment; preparations for medical and veterinary purposes, namely mineral coated particles, artificial and synthetic resins in the form magnetic or superparamagnetic particles, for use in isolating nucleic acids or proteins; chemical, biochemical and biotechnological preparations, in particular reagents, enzymes and buffer solutions for sample preparation and for marking, separating, isolating, purifying and/or for the analysis of biopolymers, in particular nucleic acids, proteins, macromolecules and biologically active substances, in particular reagents, enzymes and buffer solutions for nucleic acid purification and enrichment; kits containing preparations for medical and veterinary purposes, in particular for sample preparation and for marking, separating, isolating, purifying and/or for the analysis of biopolymers, in particular nucleic acids, proteins, macromolecules and biologically active substances, in particular reagents, enzymes and buffer solutions for nucleic acid purification and enrichment

Filing History

NOTICE OF REGISTRATION CONFIRMATION EMAILED
May 12, 2026 NRCC
REGISTERED-PRINCIPAL REGISTER
May 12, 2026 R.PR
EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
Apr 16, 2026 ETOP
POST PUBLICATION AMENDMENT - ENTERED
Mar 31, 2026 CHPB
ASSIGNED TO PETITION STAFF
Mar 31, 2026 APET
TEAS POST PUBLICATION AMENDMENT RECEIVED
Feb 2, 2026 EPPA
EXTENSION OF TIME TO OPPOSE RECEIVED
Nov 6, 2025 ETOF
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Oct 7, 2025 NPUB
PUBLISHED FOR OPPOSITION
Oct 7, 2025 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Oct 1, 2025 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Sep 10, 2025 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Aug 19, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Aug 19, 2025 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Aug 19, 2025 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jun 9, 2025 GNRN
NON-FINAL ACTION E-MAILED
Jun 9, 2025 GNRT
NON-FINAL ACTION WRITTEN
Jun 9, 2025 CNRT
ASSIGNED TO EXAMINER
May 27, 2025 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Apr 27, 2025 NWOS
NEW APPLICATION ENTERED
Dec 8, 2024 NWAP